CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Open-market sale Director sold 1,000 shares at $32.73 ($32,730)
- 4 Open-market sale Director sold 1,000 shares at $30.00 ($30,000)
- 4 Open-market sale Director sold 8,787 shares at an average $35.59 ($312,710)
- 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 12,224 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 2,445 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Med Dev/Med Affairs, CMO gave up 1,178 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CLO, Alkermes, Inc. gave up 1,620 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Alks Inc; CFO ALKS gave up 2,445 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Finance & CAO, Alks Inc. gave up 1,178 shares (to pay taxes)
- 4 Open-market sale Director sold 1,000 shares at $36.45 ($36,450)
- 4 Open-market sale Director sold 1,000 shares at $37.51 ($37,510)
- 4 Open-market sale Director sold 1,000 shares at $42.42 ($42,420)
- 4 Open-market sale Director sold 1,000 shares at $44.58 ($44,580)
- 4 Open-market sale Director sold 1,000 shares at $43.68 ($43,680)
- 4 Open-market sale Director sold 20,000 shares at $43.95 ($879,024)
- 4 Open-market sale Director sold 1,000 shares at $41.86 ($41,860)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP, Alks Inc; CFO ALKS sold 16,842 shares at $50.00 ($842,179)
- 4 Shares withheld for taxes SVP, Med Dev/Med Affairs, CMO gave up 369 shares (to pay taxes)
- 4 Open-market sale Director sold 1,000 shares at $47.34 ($47,340)
Page 25 of 67 · 1,323 filings